Angiogenesis-inhibitors for metastatic thyroid cancer-Reference-Cited by-同舟云学术

Angiogenesis-inhibitors for metastatic thyroid cancer

Published:2010-03-17 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Tan Aihua¹,Xia Ning¹,Gao Feng²,Mo Zengnan¹,Cao Yunfei¹

Affiliation:

1. First Affiliated Hospital, Guangxi Medical University; Center of Evidence Based Medicine; Taoyuan Road Nanning Guangxi China 530001

2. First Affiliated Hospital, Guangxi Medical University; Department of General Surgery; Taoyuan Road Nanning Guangxi China 530001

Publisher

Wiley

Subject

Pharmacology (medical)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/14651858.CD007958.pub2/fullpdf

Reference56 articles.

1. Preliminary results of an open labelled phase 2 study evaluating the safety and efficacy of sorafenib in metastatic advanced thyroid cancer (abstract 6060);Ahmed;Journal of Clinical Oncology,2008

2. Phase II trial of thalidomide for therapy of radioiodine-unresponsive and rapidly progressive thyroid carcinomas;Ain;Thyroid,2007

3. Phase II study of lenalidomide in distantly metastatic, rapidly progressive, and radioiodine-unresponsive thyroid carcinomas: Preliminary results (abstract 6027);Ain;Journal of Clinical Oncology,2008

4. Phase 2 study of sunitinib in refractory thyroid cancer (abstract 6025);Cohen;Journal of Clinical Oncology,2008

5. Axitinib is an active treatment for all histologic subtypes of advanced thyroid cancer: Results from a phase II study;Cohen;Journal of Clinical Oncology,2008

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of CD40 gene polymorphisms on the risk of cervical squamous cell carcinoma: a case-control study;BMC Cancer;2023-09-11

2. Sporadic Medullary Thyroid Carcinoma: Towards a Precision Medicine;Frontiers in Endocrinology;2022-03-29

3. Primary cell cultures for the personalized therapy in aggressive thyroid cancer of follicular origin;Seminars in Cancer Biology;2022-02

4. Vascular endothelial growth factor (VEGF) targeting therapy for persistent, recurrent, or metastatic cervical cancer;Cochrane Database of Systematic Reviews;2021-03-04

5. Molecular targets of tyrosine kinase inhibitors in thyroid cancer;Seminars in Cancer Biology;2020-11